# Nuclide record delphine-chen (person). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/people/delphine-chen/>
  a schema:Person ;
  nuclide:kind "person" ;
  schema:identifier "delphine-chen" ;
  schema:name "Delphine L. Chen"@en ;
  schema:description "A Seattle-based nuclear medicine physician-scientist who ran the first human trial of a PET tracer that shows whether a tumour will respond to PARP-inhibitor drugs, and who now directs nuclear medicine and molecular imaging therapy at the Fred Hutchinson Cancer Center."@en ;
  schema:url <https://nuclide.cc/people/delphine-chen/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.fredhutch.org/en/faculty-lab-directory/chen-delphine.html>, <https://rad.uw.edu/people/dlchen7> ;
  nuclide:tag "PARP PET", "clinician-scientist" ;
  schema:jobTitle "Professor, Clinical Research Division, Fred Hutchinson Cancer Center; Professor of Radiology, University of Washington; Clinical Research Director for Radiology, Fred Hutch (from January 2026; Director of Molecular Imaging and Therapy, Fred Hutch, since 2019)" ;
  nuclide:related <https://nuclide.cc/technologies/parp-pet/>, <https://nuclide.cc/targets/parp/>, <https://nuclide.cc/institutions/snmmi/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/ga-68/> .